Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital
NCT ID: NCT01140243
Last Updated: 2013-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2010-07-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263
Post-Discharge Growth and Development of Infants Who Received Targeted Fortification in the NICU
NCT04190875
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital
NCT01766011
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
NCT02943746
Human Milk-derived Fortification in Preterm Infants
NCT05228847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
test product
Dietary supplement
LCPUFA
premature infant formula supplemented with LCPUFA
standart
Dietary supplement
LCPUFA
premature infant formula supplemented with LCPUFA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LCPUFA
premature infant formula supplemented with LCPUFA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* whose mothers are unable to breast feed or have chosen not to breast feed,
* Whose parents have signed the informed consent form.
* Only the first among twins will be recorded for the study.
Exclusion Criteria
* Metabolic abnormalities.
* Central nervous system abnormalities.
* Severe developmental disorders.
* GI problems, GI surgery, necrotizing enterocolitis (NEC), gastro-esophageal reflux disease (GERD) requiring nutritional intervention.
* Milk allergy or intolerance.
* Growth failure.
* Chronic disease
2 Weeks
6 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Materna Laboratories
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neonatal Intensive Care Unit, Barzilai Medical Center
Ashkelon, , Israel
Sharei Zedek MC
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.